Cargando…
Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
Osteosarcoma (OS) is rare cancer with bimodal age distribution with peaks observed in children and young adults. Typically, OS is treated with pre-surgery neoadjuvant therapy, surgical excision, and post-surgery chemotherapy. However, the efficacy of treatment on disease prognosis and objective resp...
Autores principales: | Hu, Xin, Wen, Yang, Tan, Lin-yun, Wang, Jie, Tang, Fan, Wang, Yi-tian, Zheng, Chuan-xi, Zhang, Yu-qi, Gong, Tao-jun, Min, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789737/ https://www.ncbi.nlm.nih.gov/pubmed/35096563 http://dx.doi.org/10.3389/fonc.2021.735254 |
Ejemplares similares
-
Exosomes and osteosarcoma drug resistance
por: Fu, Huichao, et al.
Publicado: (2023) -
Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway
por: Liu, Bo, et al.
Publicado: (2019) -
The Regulatory Effects of Long Noncoding RNA-ANCR on Dental Tissue-Derived Stem Cells
por: Jia, Qian, et al.
Publicado: (2016) -
Long-Noncoding RNA ANCR Activates the Hedgehog Signaling Pathway to Promote Basal Cell Carcinoma Progression by Binding to PTCH
por: Wu, Hongxuan, et al.
Publicado: (2022) -
Expression of ANCR in nasopharyngeal carcinoma patients and its clinical significance
por: Guo, Chengbing, et al.
Publicado: (2021)